BioCentury | Jan 18, 2016
Clinical News

AF-130: Phase I started

...of AF-130 in about 64 healthy volunteers. The second part will evaluate once-daily doses of AF-130...
...21, 2009). Afferent Pharmaceuticals Inc. , San Mateo, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: AF-130...
Items per page:
1 - 1 of 1